It is a consumer electronics & durables private limited company based in Secunderabad, Telangana, India, established in 2019.
2019 | Secunderabad, Telangana, India | ActiveMark Therapeutics Private Limited, a active private limited company, was established on 22 August 2019 in Secunderabad, Telangana, India. Engaging in electronic appliances retail & distribution within the consumer electronics & durables sector, it holds CIN: U73100TG2019PTC134971. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Srinivas Naga Laxmi Narasimha Kota (Director), Kota Krishna Prasad (Director), Kumbha Roja Ramani (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at # 12-10-587/2/B, Road No 4, Medibhavi, Seethafalmandi,, Secunderabad, Telangana, 500061.
U73100TG2019PTC134971
134971
22 August 2019
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Mark Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivas Naga Laxmi Narasimha Kota | Director | 22 Aug 2019 | Current |
| Kota Krishna Prasad | Director | 22 Aug 2019 | Current |
| Kumbha Roja Ramani | Director | 22 Aug 2019 | Current |
| Vemuri Mohan Chari | Director | 22 Aug 2019 | Current |
| Aruna Sree Marasanapalli Kalle | Director | 22 Aug 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mark Therapeutics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Mark Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mark Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mark Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mark Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mark Therapeutics Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Mark Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was recorded as a recent event.
Progress on Srinivas Naga Laxmi Narasimha Kota was appointed as a Director was appointed as a Director on 22 Aug 2019 & has been associated with this company since 6 years 3 months . was documented.
Kota Krishna Prasad was appointed as a Director was appointed as a Director on 22 Aug 2019 & has been associated with this company since 6 years 3 months . was recorded as a recent event.
The activity Kumbha Roja Ramani was appointed as a Director was appointed as a Director on 22 Aug 2019 & has been associated with this company since 6 years 3 months . was completed.
The activity Vemuri Mohan Chari was appointed as a Director was appointed as a Director on 22 Aug 2019 & has been associated with this company since 6 years 3 months . was completed.
The CIN of Mark Therapeutics Private Limited is U73100TG2019PTC134971.
Mark Therapeutics Private Limited is headquartered at # 12-10-587/2/B, Road No 4, Medibhavi, Seethafalmandi,, Secunderabad, Telangana, 500061.
Mark Therapeutics Private Limited was incorporated on 22 August 2019.
The current directors of Mark Therapeutics Private Limited are
The primary industry of Mark Therapeutics Private Limited is Consumer Electronics & Durables.
Mark Therapeutics Private Limited is unlisted.
The authorized capital of Mark Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX